0001209191-19-011489.txt : 20190220 0001209191-19-011489.hdr.sgml : 20190220 20190220160407 ACCESSION NUMBER: 0001209191-19-011489 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190216 FILED AS OF DATE: 20190220 DATE AS OF CHANGE: 20190220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bowden Christopher CENTRAL INDEX KEY: 0001608601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 19618252 MAIL ADDRESS: STREET 1: 38 SIDNEY STREET, 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-16 0 0001439222 AGIOS PHARMACEUTICALS INC AGIO 0001608601 Bowden Christopher C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer Common stock 2019-02-16 4 M 0 2750 A 8013 D Common stock 2019-02-19 4 F 0 818 58.03 D 7195 D Restricted stock unit 2019-02-16 4 M 0 2750 0.00 D Common stock 2750 5500 D Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Includes 34 shares purchased through the Company's employee stock purchase plan. The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. William Cook, as Attorney-in-fact for Christopher Bowden 2019-02-20